These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 2439714

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. How safe is the treatment of impotence with intracavernous autoinjection?
    Zentgraf M, Ludwig G, Ziegler M.
    Eur Urol; 1989; 16(3):165-71. PubMed ID: 2663519
    [Abstract] [Full Text] [Related]

  • 3. Peyronie's-like plaque after penile injection of prostaglandin E1.
    Chen J, Godschalk M, Katz PG, Mulligan T.
    J Urol; 1994 Sep; 152(3):961-2. PubMed ID: 8051767
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
    Yasumoto R, Asakawa M, Kawashima H, Yoshimura R, Maekawa T, Kashiwara N, Tanaka H, Nishio S.
    Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
    [Abstract] [Full Text] [Related]

  • 9. Intracavernous injection therapy: analysis of results and complications.
    Lakin MM, Montague DK, VanderBrug Medendorp S, Tesar L, Schover LR.
    J Urol; 1990 Jun; 143(6):1138-41. PubMed ID: 2342174
    [Abstract] [Full Text] [Related]

  • 10. Comparison of a mixture of papaverine, phentolamine and prostaglandin E1 with other intracavernous injections.
    Meinhardt W, Lycklama à Nijeholt AA, Kropman RF, Vermeij P, Zwartendijk J.
    Eur Urol; 1994 Jun; 26(4):319-21. PubMed ID: 7713130
    [Abstract] [Full Text] [Related]

  • 11. Classification of sexual dysfunction for management of intracavernous medication-induced erections.
    Fein RL.
    J Urol; 1990 Feb; 143(2):298-301. PubMed ID: 1688954
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Intracavernous self-injection for impotence: a long-term therapeutic option? Experience in 78 patients.
    Girdley FM, Bruskewitz RC, Feyzi J, Graversen PH, Gasser TC.
    J Urol; 1988 Nov; 140(5):972-4. PubMed ID: 3172370
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence.
    Zorgniotti AW, Lefleur RS.
    J Urol; 1985 Jan; 133(1):39-41. PubMed ID: 2578067
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.